首页> 外文OA文献 >A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes

【2h】

A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes

机译：2B期，用于治疗斑块牛皮癣的木薯乳膏的随机临床试验：二次疗效和患者报告的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Linda Stein Gold; Neal Bhatia; Anna M. Tallman; David S. Rubenstein;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis [J] . Robbins Kevin, Bissonnette Robert, Maeda-Chubachi Tomoko, Journal of the American Academy of Dermatology . 2019,第3期

机译：Tapinarof（GSK2894512霜）治疗斑块牛皮癣的阶段2，随机剂量寻找研究
2. Efficacy, safety and patient-reported outcomes up to 52 weeks with tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomised, Phase 3 trials [J] . Papp Kim, Krueger James, Feldman Steven, The Journal of investigative dermatology. . 2015,第Suppla3期

机译：口服Janus激酶抑制剂tofacitinib治疗慢性斑块状牛皮癣的功效，安全性和患者报告的结果长达52周：两项随机的3期随机试验的结果
3. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial [J] . Ohtsuki Mamitaro, Okubo Yukari, Komine Mayumi, The Journal of dermatology . 2017,第8期

机译：Apremilast，一种口服磷酸二酯酶4抑制剂，治疗日本患者中度至重度斑块牛皮癣：疗效，安全性和可耐受性来自相2b随机对照试验
4. Estimation of Causal Effect on Treatment on Longitudinal Binary Outcomes in Randomized Clinical Trials with Non-compliance [C] . LI Xiaotong 2008年国际应用统计学术研讨会（2008 International Institute of Applied Statistics Studies）论文集 . 2008

机译：在不合规的随机临床试验中对纵向二元结局的治疗因果关系评估
5. Nonparametric and Semiparametric Inference for Treatment Efficacy in Randomized Clinical Trials with a Time-to-event Outcome and Non-compliance. [D] . Zhou, Ying. 2010

机译：非参数和半参数推论具有事件发生时间和不依从性的随机临床试验的疗效。
6. Apremilast an oral phosphodiesterase 4 inhibitor in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy safety and tolerability results from a phase 2b randomized controlled trial [O] . Mamitaro Ohtsuki, Yukari Okubo, Mayumi Komine, -1

机译：Apremilast一种口服磷酸二酯酶4抑制剂用于治疗中度至重度斑块状牛皮癣的日本患者：2b期随机对照试验的疗效安全性和耐受性
7. Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study [O] . Mark Lebwohl, James Q Del Rosso, Chih-Ho Hong, 2020

机译：Tapinarof霜用于治疗斑块牛皮癣：基线疾病特征和皮肤型在2B期随机研究中的疗效和安全性

A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes

著录项

引文网络

相似文献

相关主题

期刊订阅